Literature DB >> 6217993

Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.

J E Garcia, G S Jones, A A Acosta, G Wright.   

Abstract

Thirty-one human menopausal gonadotropin and human chorionic gonadotropin (hMG/hCG) ovulation induction cycles from 25 normally ovulating patients who applied to a program for the Vital Initiation of Pregnancy (VIP) are discussed. Three different categories of serum estradiol (E2) response were found. Serum E2 and progesterone responses were inversely related to the amount of hMG, indicating a patient sensitivity rather than a dosage relationship. Luteinizing hormone levels were suppressed by gonadotropins. Daily evaluation of vaginal smear, cervical mucus, serum E2 determinations, and pelvic ultrasound are necessary for an optimum ovulation induction with gonadotropins. Two successful pregnancies are reported.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6217993     DOI： 10.1016/s0015-0282(16)46814-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  19 in total

1.  Identification of follicles with fertilizable oocytes by sequential ultrasound measurements during follicular development.

Authors:  J J Peluso; M Damien; J C Nulsen; A A Luciano
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

2.  Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol.

Authors:  M P Diamond; W S Maxson; W K Vaughn; K G Osteen; A C Wentz
Journal:  J In Vitro Fert Embryo Transf       Date:  1986-04

3.  Preovulatory serum gonadotropin levels in hMG stimulated menstrual cycles in pregnant and nonpregnant patients.

Authors:  J F van Uem; A A Acosta; J E Garcia; Z Rosenwaks
Journal:  Arch Gynecol       Date:  1987

4.  Meta-analysis of GnRH-antagonists versus GnRH-agonists in poor responder protocols.

Authors:  Myrto Papamentzelopoulou; Sofoklis Stavros; Despoina Mavrogianni; Christos Kalantzis; Dimitrios Loutradis; Petros Drakakis
Journal:  Arch Gynecol Obstet       Date:  2021-01-10       Impact factor: 2.344

5.  Is analgesia required for transvaginal single-follicle aspiration in in vitro fertilization? A double-blind study.

Authors:  S S Ramsewak; A Kumar; R Welsby; A Mowforth; E A Lenton; I D Cooke
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-04

Review 6.  Drugs used in in vitro fertilisation procedures.

Authors:  I E Messinis
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

7.  A Mobile Oocyte Incubation Unit (MOIU): a device for improvement of the gamete intrafallopian transfer (GIFT) program.

Authors:  M T Shih; M H Yu; T Y Chu; D Sun; C K Lee; C T Hsu
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-08

Review 8.  Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.

Authors:  T Levy; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

9.  In vitro fertilization in Norfolk, Virginia, 1980-1983.

Authors:  J Garcia; A Acosta; M C Andrews; G S Jones; H W Jones; T Mantzavinos; J Mayer; J McDowell; B Sandow; L Veeck
Journal:  J In Vitro Fert Embryo Transf       Date:  1984-03

10.  Comparison of human menopausal gonadotropin administered once and twice daily in an in vitro fertilization and embryo transfer program.

Authors:  A A Murphy; H W Michelman; H H Riedel; M Grillo; L Mettler
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.